Inventor · disambiguated record
John Lydeard
Also filed as: LYDEARD JOHN
9 granted patents·17 pending applications·34 citations·filing 2018–2024
88Inventor score
Top patents by PatentIndex Score
26 records- 0196US11571445B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Feb 7, 2023·4 cites·21 claims
- 0296US11559551B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Jan 24, 2023·5 cites·18 claims
- 0396US11382932B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Jul 12, 2022·4 cites·25 claims
- 0496US10925902B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2019·Granted Feb 23, 2021·8 cites·19 claims
- 0595US11903973B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Feb 20, 2024·3 cites·31 claims
- 0695US11464807B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Oct 11, 2022·5 cites·22 claims
- 0793US11389485B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2019·Granted Jul 19, 2022·4 cites·20 claims
- 0881US11975029B2Compositions and methods for inhibition of lineage specific proteinsVOR BIOPHARMA INC·Filed 2018·Granted May 7, 2024·1 cites·19 claims
- 0981US2023053285A1Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1075US2024350550A1Compositions and methods for inhibition of lineage specific proteinsVOR BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1173US12251403B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2020·Granted Mar 18, 2025·0 cites·18 claims
- 1267US2025295695A1Compositions and methods for mediating epitope engineeringVOR BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1360US2025179531A1Compositions and methods for homology-directed repair gene modificationVOR BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1457US2023364233A1Compositions and methods for cd6 modificationLYDEARD JOHN·Filed 2021·Application pending·0 cites
- 1557US2024344058A1Compositions and methods for bcma modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1657US2023364146A1Compositions and methods for cd30 gene modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1757US2023398219A1Compositions and methods for cd38 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1857US2024033290A1Compositions and methods for cd7 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1957US2024041932A1Compositions and methods for cd5 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2056US2024238344A1Compositions and methods for cd123 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2156US2024000846A1Compositions and methods for treating hematopoietic malignancyVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2255US2024110189A1Compositions and methods for cll1 modificationVOR BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2355US2024408234A1Compositions and methods for multiplex base editing in hematopoietic cellsVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2454US2022290160A1Compositions and methods for cll1 modificationVOR BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2551US2022333116A1Compositions and methods for cd123 modificationVOR BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 2649US2022228153A1Compositions and methods for cd33 modificationVOR BIOPHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Lydeard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →